Eli Lilly and Co (NYSE:LLY) - Share price - Overview


Stock Report

Eli Lilly and Co LLY

Last Price
$131.02

Day Change
1.15|0.89%

As of 26/03/2019
16:14:54 EDT | USD
Minimum 15 Minutes Delay.

Last Close129.87
Day Range129.70 - 132.13
Mkt Cap127.10Bil
52-Wk Range74.65 - 132.13
Yield %1.78
ISINUS5324571083
Volume5,509,353
P/E41.86
P/S5.52
P/CF24.51

Share Price

Financials
201620172018
More ...
Income Statement
Revenue21,222.1022,871.3024,555.70
Operating Income3,871.304,931.206,428.90
Net Income2,737.60-204.103,232.00
Basic EPS2.59-0.193.14
Avg. Diluted Shares Outstanding1,0621,0521,034
Balance Sheet
Current Assets15,101.4019,202.1020,549.60
Non Current Assets23,704.5025,778.9023,358.80
Total Assets38,805.9044,981.0043,908.40
Current Liabilities10,986.6014,535.9011,888.10
Total Liabilities24,725.4033,313.1032,999.30
Total Equity14,007.7011,592.209,828.70
Cash Flow
Operating Cash Flow4,851.005,615.605,524.50
Capital Expenditure-1,092.00-2,163.60-3,018.20
Free Cash Flow3,759.003,452.002,506.30

In millions, except "Basic EPS". Currency is USD.

Company Profile

Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.

Sector

Healthcare

Industry

Drug Manufacturers - Major

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

38,680
Key Stats
More ...
Price/Earning TTM41.36
Price/Book12.82
Price/Sales TTM5.47
Rev Growth (3 year avg)7.15
EPS Growth (3 year avg)-
Operating Margin % TTM26.18
Net Margin % TTM13.16
ROE TTM30.18
Debt/Equity1.18
Dividends
PreviousLatest
More ...
Declared Date15/10/1819/12/18
Ex-Div14/11/1814/02/19
Paid10/12/1808/03/19
Amnt0.560.65
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.